HOMETeaching & LecturesFaculty
Name: Paul Zhou Discipline: Immunology
Academic degree: M.D., Ph.D Academic title: Professor
Phone: 021-63851390 Fax: 021-63843571
Position: Principal Investigator
E-mail: blzhou@sibs.ac.cn
Mailing Address: 225 south chongqing road,shanghai
1978-1983 B. Med. Shanghai Second Medical University,           Shanghai,China (Medicine);
1985-1987 M. A., State University of New York at Buffalo, Buffalo, NY;
1985-1989 Ph. D. State University of New York at Buffalo, Buffalo, NY (Immunology)。
Professional appointments:
1983-1985 Postgraduate study, Shanghai Institute of Immunology, Shanghai, China;
1985-1989 Research/Teaching Assistant, Department of Microbiology, School of Medicine, State University of New York at Buffalo, Buffalo, NY;
1989-1993 Postdoctoral Fellow, Department of Immunology, Mayo Clinic, Rochester, MN;
1993-1998 Senior Staff Fellow, Oral Infection and Immunity Branch, National Institutes of Health, Bethesda, MD;
1998-2005 Principal Investigator, Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX;
1999-2005 Adjunct Associate Professor, Department of Microbiology, University of Texas Health Science Center at San Antonio, San Antonio, TX;
2001-2005 Affiliate member of the Southwest National Primate Center, San Antonio, TX;
2005-present Professor &Principal Investigator, Institut Pasteur of Shanghai, Chinese Academy of Sciences。
Research direction: Antiviral Immunity and Genetic Therapy
Awards & Honors:
Research grants:

Project Leader in the grant funded by the Li Kai-Shing Foundation entitled “Optimization of influenza HA-based pseudotypes and their use in development of a novel neutralizing assay” (07-01-06 to 06-30-09);
Project Leader in the Chinese Ministry of Science and Technology 973 program grant 2006CB504308 entitled “Anti-viral Immunity: Basic Science and Therapeutic Applications” (01-01-07 to 12-31-11);
Principal Investigator in the National Science Foundation grant #30671922 entitled “Develop a chimeric HA-based vaccine strategy against avian influenza” (01-01-07 to 12-31-09);
Principal Investigator in the CAS Innovative grant #KSCX1-YW-R-08 entitled “Foamy virus-based pseudotypes” (10-01-06 to 12-31-09);
Principal Investigator in the Shanghai Pasteur Foundation program grant entitled “Develop humanized mouse model for evaluating efficacy and safety of vaccine candidates against HIV” (01-01-08 to 12-31-11);
Project Leader in the Grand Science and Technology Special Project on Vaccine against HIV 2008ZX1001-1010-03 entitled “Research on VLP” (10-01-08 to12-31-10)

Membership in professional associations:
Link: Antiviral immunity and genetic therapy